Risk factors for deep vein thrombosis and pulmonary embolism -: A population-based case-control study

被引:1729
作者
Heit, JA
Silverstein, MD
Mohr, DN
Petterson, TM
O'Fallon, WM
Melton, LJ
机构
[1] Mayo Clin & Mayo Fdn, Div Cardiovasc Dis, Rochester, MN 55905 USA
[2] Mayo Clin & Mayo Fdn, Hematol Res Sect, Rochester, MN 55905 USA
[3] Mayo Clin & Mayo Fdn, Div Area Gen Internal Med, Rochester, MN 55905 USA
[4] Mayo Clin & Mayo Fdn, Dept Internal Med, Rochester, MN 55905 USA
[5] Mayo Clin & Mayo Fdn, Clin Epidemiol Sect, Rochester, MN 55905 USA
[6] Mayo Clin & Mayo Fdn, Biostat Sect, Rochester, MN 55905 USA
[7] Mayo Clin & Mayo Fdn, Dept Hlth Sci Res, Rochester, MN 55905 USA
关键词
D O I
10.1001/archinte.160.6.809
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Background: Reported risk factors for venous thromboembolism (VTE) vary widely, and the magnitude and independence of each are uncertain. Objectives: To identified independent risk factors for deep vein thrombosis and pulmonary embolism and to estimate the magnitude of risk for each. Patients and Methods: We performed a population based, nested, case-control study of 625 Olmsted County, Minnesota, patients with a first lifetime VTE diagnosed during the 15-year period from January 1, 1976, through December 31, 1990, and 625 Olmsted County patients without VTE. The 2 groups were matched on age, sex, calendar year, and medical record number. Results: Independent risk factors for VTE included surgery (odds ratio [OR], 21.7; 95% confidence interval [CI], 9.4-49.9), trauma (OR, 12.7; 95% CI, 4.1-39.7), hospital or nursing home confinement (OR, 8.0; 95% CI, 4.5-14.2), malignant neoplasm with (OR, 6.5; 95% CI, 2.1-20.2) or without (OR, 4.1;95% CI, 1.9-8.5) chemotherapy, central venous catheter or pacemaker (OR, 5.6, 95% CI, 1.6-19.6), superficial vein thrombosis (OR, 4.3; 95% CI, 1.8-10.6), and neurological disease with extremity paresis (OR, 3.0; 95% CI, 1.3-7.4). The risk associated with varicose veins diminished with age (for age 45 years: OR, 4.2; 95% CI, 1.6-11.3, for age 60 years: OR, 1.9; 95% CI, 1.0-3.6; for age 75 years: OR, 0.9; 95% CI, 0.6-1.4),while patients with liver disease had a reduced risk (OR, 0.1; 95% CI, 0.0-0.7). Conclusion: Hospital or nursing home confinement, surgery, trauma, malignant neoplasm, chemotherapy, neurologic disease with paresis, central venous catheter or pacemaker, varicose veins, and superficial vein thrombosis are independent and important risk factors for VTE.
引用
收藏
页码:809 / 815
页数:7
相关论文
共 42 条
[1]   A POPULATION-BASED PERSPECTIVE OF THE HOSPITAL INCIDENCE AND CASE-FATALITY RATES OF DEEP-VEIN THROMBOSIS AND PULMONARY-EMBOLISM - THE WORCESTER DVT STUDY [J].
ANDERSON, FA ;
WHEELER, HB ;
GOLDBERG, RJ ;
HOSMER, DW ;
PATWARDHAN, NA ;
JOVANOVIC, B ;
FORCIER, A ;
DALEN, JE .
ARCHIVES OF INTERNAL MEDICINE, 1991, 151 (05) :933-938
[2]  
BORS E, 1954, SURG GYNECOL OBSTET, V99, P451
[3]  
BROMFIELD EB, 1988, J NEUROL REHABIL, V2, P51
[4]   Epidemiology of oral contraceptives and cardiovascular disease [J].
Chasan-Taber, L ;
Stampfer, MJ .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (06) :467-477
[5]   Prevention of venous thromboembolism [J].
Clagett, GP ;
Anderson, FA ;
Geerts, W ;
Heit, JA ;
Knudson, M ;
Lieberman, JR ;
Merli, GJ ;
Wheeler, HB .
CHEST, 1998, 114 (05) :531S-560S
[6]   ACQUIRED RISK-FACTORS FOR DEEP-VEIN THROMBOSIS IN SYMPTOMATIC OUTPATIENTS [J].
COGO, A ;
BERNARDI, E ;
PRANDONI, P ;
GIROLAMI, B ;
NOVENTA, F ;
SIMIONI, P ;
GIROLAMI, A .
ARCHIVES OF INTERNAL MEDICINE, 1994, 154 (02) :164-168
[7]   VENOUS THROMBOEMBOLISM AND OTHER VENOUS DISEASE IN TECUMSEH-COMMUNITY-HEALTH-STUDY [J].
COON, WW ;
WILLIS, PW ;
KELLER, JB .
CIRCULATION, 1973, 48 (04) :839-846
[8]  
COON WW, 1976, SURG GYNECOL OBSTET, V143, P385
[9]  
COON WW, 1959, SURG GYNECOL OBSTET, V109, P487
[10]   Risk of venous thromboembolism in users of hormone replacement therapy [J].
Daly, E ;
Vessey, MP ;
Hawkins, MN ;
Carson, JL ;
Gough, P ;
Marsh, S .
LANCET, 1996, 348 (9033) :977-980